Literature DB >> 12465727

Expression of osteopontin (Eta-1) in Crohn disease of the terminal ileum.

N Gassler1, F Autschbach, S Gauer, J Bohn, B Sido, H F Otto, H Geiger, N Obermüller.   

Abstract

BACKGROUND: The causes of Crohn disease (CD) are still regarded as unknown, but impaired mucosal immunoregulation with activation of T-helper-1 (Th-1) cytokine responses is probably involved and may contribute to the morphological changes. We investigated a possible role of osteopontin (Opn) in the pathogenesis of CD. This glycoprotein has been suggested to be involved in the generation of Th-1-type immune responses; moreover, it carries anti-inflammatory activities.
METHODS: Ileal samples from CD patients--both actively inflamed and inactive areas as well as unaffected intestinal specimens from controls (normal ileum)--were investigated by Western blot analysis, immunohistochemistry and in situ hybridization.
RESULTS: In normal gut, Opn was found to be regularly expressed by plasma cells (CD 38) and a subset of lamina propria mononuclear cells (MNC) as well as by intestinal epithelial cells (IEC). In active CD, immunohistochemistry and in situ hybridization analysis revealed a loss of Opn expression by IEC adjacent to ulcerative lesions, whereas especially plasma cells (CD 38) in the vicinity of such lesions were found to express the molecule. In addition, a slight overexpression of Opn protein was found in metaplastic crypts. However, quantitative analysis of total Opn protein in the ileal mucosa of CD patients did not reveal any difference vis-à-vis control tissues.
CONCLUSIONS: The constitutive expression of Opn in normal gut indicates that it is involved in intestinal immune homeostasis. Downregulation of Opn expression in IEC might favour the disintegration of the epithelial barrier. The expression of Opn in lamina propria plasma cells could contribute to disease chronification, probably by affecting cell survival.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12465727     DOI: 10.1080/003655202761020560

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  18 in total

1.  Osteopontin biomarker in inflammatory bowel disease, animal models and target for drug discovery.

Authors:  Manuela G Neuman
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

2.  Osteopontin: a new addition to the constellation of cytokines which drive T helper cell type 1 responses in Crohn's disease.

Authors:  J N Gordon; T T MacDonald
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

3.  The differences between the localizations of MUC1, MUC5AC, MUC6 and osteopontin in quail proventriculus and gizzard may be a reflection of functional differences of stomach parts.

Authors:  Narin Liman; Emel Alan; Güner Küçük Bayram
Journal:  J Anat       Date:  2010-05-11       Impact factor: 2.610

4.  Distinct immunohistochemical expression of osteopontin in the adult rat major salivary glands.

Authors:  Nicholas Obermüller; Nikolaus Gassler; Norbert Gretz; Bettina Kränzlin; Sigrid Hoffmann; Helmut Geiger; Stefan Gauer
Journal:  J Mol Histol       Date:  2006-07-03       Impact factor: 2.611

5.  Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response.

Authors:  T Sato; T Nakai; N Tamura; S Okamoto; K Matsuoka; A Sakuraba; T Fukushima; T Uede; T Hibi
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

6.  The cytokine osteopontin modulates the severity of rotavirus diarrhea.

Authors:  Ellen E Rollo; Scott J Hempson; Ajay Bansal; Ernest Tsao; Iman Habib; Susan R Rittling; David T Denhardt; Erich R Mackow; Robert D Shaw
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets.

Authors:  Georgina Xanthou; Themis Alissafi; Maria Semitekolou; Davina C M Simoes; Erasmia Economidou; Mina Gaga; Bart N Lambrecht; Clare M Lloyd; Vily Panoutsakopoulou
Journal:  Nat Med       Date:  2007-04-15       Impact factor: 53.440

8.  Plasma osteopontin predicts inflammatory bowel disease activities.

Authors:  Shihoko Komine-Aizawa; Hideki Masuda; Takerou Mazaki; Motomi Shiono; Satoshi Hayakawa; Tadatoshi Takayama
Journal:  Int Surg       Date:  2015-01

9.  Osteopontin Protects Colonic Mucosa from Dextran Sodium Sulfate-Induced Acute Colitis in Mice by Regulating Junctional Distribution of Occludin.

Authors:  Sang-Ho Woo; Su-Hyung Lee; Jun-Won Park; Du-Min Go; Dae-Yong Kim
Journal:  Dig Dis Sci       Date:  2018-08-27       Impact factor: 3.199

10.  Osteopontin: participation in inflammation or mucosal protection in inflammatory bowel diseases?

Authors:  Fengyuan Chen; Hongchun Liu; Qiang Shen; Shengzhong Yuan; Lin Xu; Xunquan Cai; Jingjing Lian; Shi-yao Chen
Journal:  Dig Dis Sci       Date:  2013-01-30       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.